Influences on PET Quantification and Interpretation
Open accessThe DOI matches its Crossref record; 226 of the 239 references it cites were found in a registry or an index; 188 of the 275 sources its claims cite were checked for support.
Abstract
Various factors have been identified that influence quantitative accuracy and image interpretation in positron emission tomography (PET).
Overview
CoChat Summary
TL;DR
This review summarizes the many patient, protocol, hardware, and reconstruction factors that affect PET quantification and visual interpretation, with emphasis on FDG-PET and newer scanner technologies. Its main message is that SUV and image appearance are highly variable, so standardized protocols, quality control, and harmonized reconstruction are needed for reliable clinical use.
Key findings
- Patient-related factors can materially change SUV in normal tissues: body mass/BMI correlates positively with body-mass–corrected SUV in several organs, and blood glucose can lower absolute [18F]FDG uptake by up to 50% when highly elevated.
- Partial volume effects become relevant at lesion diameters of about 10 mm; with a 4 mm FWHM PSF, reported recovery of maximum activity is 97% at 10 mm, 86% at 8 mm, and 63% at 6 mm.
- PET/CT and PET/MRI can differ systematically: MR-based attenuation correction can cause SUV errors, with reported underestimation in bone tissue or lesions close to bone of >10% versus PET/CT, and phantom sphere SUV differences of 10–20%.
- Newer hardware/reconstruction can improve performance but also shift quantification: SiPM scanners and TOF/PSF/penalized-likelihood reconstruction generally improve sensitivity, SNR, lesion contrast, and detection; PSF reconstruction can increase lesion SUVmax, SUVmean, and SUVpeak by up to 30% on average.
- Even with improved quantification, routine clinical SUV thresholds remain hard to generalize because SUV test-retest variability in the same patient can be up to 20%, and the paper states that it has not been possible to prove that quantitative measures provide additional value over visual assessment alone for routine diagnostics.
Methods
- Narrative review of factors influencing PET quantification and interpretation, with special attention to [18F]FDG and recent PET technology.
- Synthesizes prior studies on patient physiology/preparation, acquisition parameters, attenuation correction, reconstruction methods, image quality, lesion detection, and reader variability.
- No original dataset or primary statistical analysis is reported in the paper itself.
Limitations
- The paper itself states that the clinical added value of quantitative uptake parameters is “still not well-defined,” and that robust, widely adoptable SUV thresholds are limited by variability and lack of harmonization.
- It also notes that many comparisons across scanners or reconstruction methods are hard to generalize because studies often differ in axial FOV, uptake time, reconstruction settings, or scan order.
- Evident from the text: this is a review, so its conclusions depend on the quality and heterogeneity of the cited literature rather than a single controlled study.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6 Fused transaxial as well as coronal PET/CT slices through residual mediastinal lymphoma tissue of a 23-year-old female patient reconstructed with the OSEM algorithm (A,B) and with OSEM combined with TOF and PSF (C,D). While the lesional [18F]FDG uptake was defined as Deauville score 3 based on OSEM reconstruction, it would exceed the liver uptake when assessed based on images reconstructed with TOF and PSF (=Deauville score 4). This could alter the assessment from “adequate” to “inadequate” metabolic response.](https://figures.cochat.ai/paper-figures/c7175ff5774d4391bae7b71dc157c952/influences-on-pet-quantification-and-interpretation-figure-6.jpg)
![Figure 7 Images of two [18F]FDG-PET/CT examinations in a 63-year-old man with hepatic and pulmonary aspergillosis. The earlier examination was performed with a scanner equipped with conventional photomultiplier tubes (PMT) and reconstructed with OSEM and TOF (A–D). The second examination after 5 months used a SiPM-equipped PET scanner and PL reconstruction with a penalization factor beta of 450 (E–H). Two pulmonary lesions that showed only moderate [18F]FDG uptake during the earlier examination (A,B) appeared substantially more intense on the second scan (E,F). However, uptake in hepatic lesions declined (not shown), and both pulmonary lesions were unaltered in the CT scan (C,G), which suggested that the higher conspicuity of the pulmonary lesions was a result of improved reconstructed spatial resolution and lesion contrast recovery (CR) with the SiPM scanner and PL reconstruction. Based on phantom measurements, reconstructed spatial resolution was estimated at 7.8 mm full width at half maximum (FWHM) with the PMT scanner and 4.7 mm with the SiPM scanner. The improvement in image sharpness can also be seen in the myocardium (D,H).](https://figures.cochat.ai/paper-figures/ac48583bedd54632adfc0f14d0323a22/influences-on-pet-quantification-and-interpretation-figure-7.jpg)
Verification
Claims the paper makes
98 Valid · 5 Not valid · 16 Not checked · 46 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Several studies on subjective image quality in whole-body [18F]FDG-PET with PL reconstruction found that image quality was highest at beta values of 450 (to 600) despite lower lesion CR or “image sharpness” at these beta values compared to lower values [41,108,112,175,179].”
§ Influences on PET Quantification and Interpretation > 3. Factors Affecting PET Interpretation > 3.3. Relationship between Objective and Subjective Image Quality
What the sources say
- Partly supportedcites [41] Rogasch, 2020, Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF), EJNMMI Phys. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Disputedcites [108] Sundin, 2018, Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for 18F-FDG Whole-Body Examinations, J. Nucl. Med. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
- Partly supportedcites [112] Messerli, 2018, Impact of a Bayesian penalized likelihood reconstruction algorithm on image quality in novel digital PET/CT: Clinical implications for the assessment of lung tumors, EJNMMI Phys. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [175] Oddstig, 2019, Impact of penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm for 18F-fluorocholine PET-CT regarding image quality and interpretation, EJNMMI Phys. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Disputedcites [179] 2018, Phantom, clinical, and texture indices evaluation and optimization of a penalized-likelihood image reconstruction method (Q.Clear) on a BGO PET/CT scanner, Med. Phys. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The patient’s physiology and constitution influence the biodistribution of radiopharmaceuticals, especially of [18F]FDG, although they mainly affect standardized uptake values (SUV) in normal organs, such as the liver, brain, lung, skeletal muscles, and blood pool [1].”
§ Influences on PET Quantification and Interpretation > 2. Factors Affecting PET Quantification > 2.1. Patient
What the sources say
- Partly supportedcites [1] Eskian, 2019, Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: A systematic review and meta-analysis of 20,807 individual SUV measurements, Eur. J. Nucl. Med. Mol. Imaging sourceExperimental — accuracy not yet measured
The Clinical points and conclusions section (page unavailable) reports that fasting hyperglycemia changes [18F]FDG uptake in the brain, muscle, liver, and mediastinal blood pool. The paper addresses blood glucose specifically, not patient physiology and constitution broadly or radiopharmaceuticals generally; its lung measurements concern lung tumors, not normal lung. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Normal brain [18F]FDG uptake varies with age, sex, and the presence or absence of diabetes mellitus [1,6,9,10].”
§ Influences on PET Quantification and Interpretation > 2. Factors Affecting PET Quantification > 2.1. Patient
What the sources say
- Partly supportedcites [1] Eskian, 2019, Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: A systematic review and meta-analysis of 20,807 individual SUV measurements, Eur. J. Nucl. Med. Mol. Imaging sourceExperimental — accuracy not yet measured
Table 4 (Clinical points and conclusions; page not provided) reports associations of brain SUVmax with age (p < 0.0001) and diabetes diagnosis (p = 0.04). It does not support the sex component: sex was not significantly associated with brain SUVmax (p = 0.245) or SUVmean (p = 0.892). The age and diabetes associations also did not extend to brain SUVmean in this analysis. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [6] Brade, 2013, Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT, Nucl. Med. Biol. source
- Partly supportedcites [9] Yoshizawa, 2014, Characterizing the normative profile of 18F-FDG PET brain imaging: Sex difference, aging effect, and cognitive reserve, Psychiatry Res. sourceExperimental — accuracy not yet measured
The abstract (p. 1) reports sex differences and age-related changes in cerebral glucose metabolism measured with 18F-FDG PET. But §2.1 (p. 2) says diabetes mellitus was an exclusion criterion, so this study does not establish variation by the presence or absence of diabetes. (LLM, conf=0.93)
- Partly supportedcites [10] Turpin, 2018, Modeling the Effects of Age and Sex on Normal Pediatric Brain Metabolism Using 18F-FDG PET/CT, J. Nucl. Med. sourceExperimental — accuracy not yet measured
The Discussion reports that normal pediatric regional brain metabolism changes with age and that sex differences are present, though their effect is limited. The paper does not report whether brain FDG uptake differs by diabetes status; its Imaging section says only that blood glucose was checked before injection. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Conversely, raising blood glucose and/or insulin levels increases [18F]FDG uptake in the liver, skeletal muscles, and myocardium mainly via GLUT2 and 4 [1,6,22].”
§ Influences on PET Quantification and Interpretation > 2. Factors Affecting PET Quantification > 2.2. Patient Preparation
What the sources say
- Partly supportedcites [1] Eskian, 2019, Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: A systematic review and meta-analysis of 20,807 individual SUV measurements, Eur. J. Nucl. Med. Mol. Imaging sourceExperimental — accuracy not yet measured
The Liver section reports higher liver FDG uptake with higher blood glucose and identifies GLUT2 as a prominent hepatic transporter. The Muscle and Clinical points and conclusions sections report the opposite of the claimed glucose effect in patients still hyperglycemic after at least four hours of fasting: muscle FDG uptake was lower. The paper discusses insulin-sensitive GLUT4 and allows that uptake might rise in acute hyperglycemia, but does not establish the claimed increase across all three tissues; the retrieved passages do not address myocardial uptake. Page numbers were unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [6] Brade, 2013, Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT, Nucl. Med. Biol. source
- Not checked — no full text of the sourcecites [22] Namba, 1994, A simple method for measuring glucose utilization of insulin-sensitive tissues by using the brain as a reference, Eur. J. Nucl. Med. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“If, for example, a SiPM system with low relative coverage of <60% and a modest timing resolution of 382 ps [44,45] is compared to a bismuth germanate (BGO) PMT scanner with similar axial FOV length [46], the SiPM system’s sensitivity can be similar or even slightly inferior (20.8 vs. 23.3 cps/kBq) [45].”
§ Influences on PET Quantification and Interpretation > 2. Factors Affecting PET Quantification > 2.4. Hardware
What the sources say
- Supportedcites [44] Surti, 2020, Update on latest advances in time-of-flight PET, Phys. Med. source
The GE Healthcare subsection reports less than 60% SiPM coverage, 382 ps TOF resolution, and 20.8 cps/kBq sensitivity for the five-ring scanner. Those are the scanner measurements attributed to this source; the citing sentence separately cites [46] for the BGO comparator. (LLM, conf=0.90)
- Partly supportedcites [45] Pan, 2019, Performance evaluation of the 5-Ring GE Discovery MI PET/CT system using the national electrical manufacturers association NU 2-2012 Standard, Med. Phys. sourceExperimental — accuracy not yet measured
The Results (PET performance evaluation; page unavailable) report 20.84 cps/kBq sensitivity and approximately 382 ps timing resolution for the SiPM scanner. The Discussion compares it with a BGO/PMT scanner of similar axial FOV and says the BGO scanner’s sensitivity was slightly higher. The passages do not establish the claimed <60% relative coverage or the BGO scanner’s specific value of 23.3 cps/kBq. (LLM, conf=0.85)
- Partly supportedcites [46] 2017, Performance Characteristics of the Whole-Body Discovery IQ PET/CT System, J. Nucl. Med. sourceExperimental — accuracy not yet measured
The Scanner Characteristics section identifies the Discovery IQ as a BGO scanner with photomultipliers, and Scanner Performance reports sensitivity of 22.80 cps/kBq at the center and 20.43 cps/kBq at 10 cm. This supports the claim’s approximate BGO sensitivity, but our copy does not report 23.3 cps/kBq or compare the scanner with a SiPM system. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
91 more claims · 54 with their cited sources checked
Create a free account to see all 165 claims and to verify the 3 references still open.
- It may state two separate claims as one. 53
- Probably not a substantial claim. 18
- The quote only partly states this claim. 2
Citations
Cites
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000 · cited 1×
“Lesional uptake of [18F]FDG is more or less irreversible in neoplastic cells [68,69] due to intracellular trapping of the phosphorylated molecule, although reversible uptake has been demonstrated in inflammatory tissue [18].”
BackgroundFrom RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303 · cited 12×
“, the assessment of generalized or focal pathologies in tracer accumulation, while quantitative parameters, including SUV, provide orientation or additional information at most [24].”
BackgroundMethodInfluentialSelf-citationHofman, M. S., Lawrentschuk, N., Francis, R. J., Tang, C., Vela, I., Thomas, P., Rutherford, N., Martin, J. M., Frydenberg, M., Shakher, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30314-7 · Cited by 2,040
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
Attenuation correction for a combined 3D PET/CT scanner
Kinahan, P. E., Townsend, D. W., Beyer, T., & Sashin, D. (1998) · Medical Physics · doi:10.1118/1.598392 · Cited by 946 · cited 1×
“g, acquired with 120 keV) into linear attenuation correction factors for 511 keV photons [57].”
BackgroundCherry, S. R., Jones, T., Karp, J. S., Qi, J., Moses, W. W., & Badawi, R. D. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.184028 · Cited by 763 · cited 15×
“Sekine et al. used a randomized protocol to investigate the potential to reduce injected [18F]FDG activity required (or acquisition time) through the use of an SiPM TOF PET/MRI instead of a PMT TOF PET/CT in 74 patients with different types of malignant tumors.”
BackgroundInfluentialPauleit, D. (2005) · Brain · doi:10.1093/brain/awh399 · Cited by 634
Eiber, M., Herrmann, K., Calais, J., Hadaschik, B., Giesel, F. L., Hartenbach, M., Hope, T., Reiter, R., Maurer, T., Weber, W. A., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.198119 · Cited by 626
(2005) · PubMed · Cited by 612
Hofman, M. S., Lau, W. F. E., & Hicks, R. J. (2015) · RadioGraphics · doi:10.1148/rg.352140164 · Cited by 561
Chen, H., Pang, Y., Wu, J., Zhao, L., Hao, B., Wu, J., Wei, J., Wu, S., Zhao, L., Luo, Z., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04769-z · Cited by 545
Fully 3-D PET reconstruction with system matrix derived from point source measurements
Panin, V. Y., Kehren, F., Michel, C., & Casey, M. (2006) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2006.876171 · Cited by 536
Physical and clinical performance of the mCT time-of-flight PET/CT scanner
Jakoby, B. W., Bercier, Y., Conti, M., Casey, M. E., Bendriem, B., & Townsend, D. W. (2011) · Physics in Medicine and Biology · doi:10.1088/0031-9155/56/8/004 · Cited by 492
Performance Characteristics of the Digital Biograph Vision PET/CT System
van Sluis, J., de Jong, J., Schaar, J., Noordzij, W., van Snick, P., Dierckx, R., Borra, R., Willemsen, A., & Boellaard, R. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.215418 · Cited by 484 · cited 2×
“This becomes especially evident with recent PET systems with extra-large axial FOV of >25 cm and their potential to substantially reduce required acquisition times [47,149,150].”
BackgroundSelf-citation(1995) · PubMed · Cited by 474
The facilitative glucose transporter GLUT3: 20 years of distinction
Simpson, I. A., Dwyer, D., Malide, D., Moley, K. H., Travis, A., & Vannucci, S. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90388.2008 · Cited by 473
Spencer, B. A., Berg, E., Schmall, J. P., Omidvari, N., Leung, E. K., Abdelhafez, Y. G., Tang, S., Deng, Z., Dong, Y., Lv, Y., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.250597 · Cited by 403
(1993) · PubMed · Cited by 398
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Ceci, F., Oprea-Lager, D. E., Emmett, L., Adam, J. A., Bomanji, J., Czernin, J., Eiber, M., Haberkorn, U., Hofman, M. S., Hope, T. A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05245-y · Cited by 368
FDG PET Evaluation of Mucinous Neoplasms: Correlation of FDG Uptake with Histopathologic Features
Berger, K. L., Nicholson, S. A., Dehdashti, F., & Siegel, B. A. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.4.1741005 · Cited by 351
Ahn, S., & Fessler, J. A. (2003) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2003.812251 · Cited by 344
Aide, N., Lasnon, C., Veit-Haibach, P., Sera, T., Sattler, B., & Boellaard, R. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3740-2 · Cited by 344
Self-citationPrenosil, G. A., Sari, H., Fürstner, M., Afshar-Oromieh, A., Shi, K., Rominger, A., & Hentschel, M. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.261972 · Cited by 338
Focus on time-of-flight PET: the benefits of improved time resolution
Conti, M. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1711-y · Cited by 335 · cited 17×
“Sekine et al. used a randomized protocol to investigate the potential to reduce injected [18F]FDG activity required (or acquisition time) through the use of an SiPM TOF PET/MRI instead of a PMT TOF PET/CT in 74 patients with different types of malignant tumors.”
BackgroundInfluentialKANG, D. E., WHITE, R. L., ZUGER, J. H., SASSER, H. C., & TEIGLAND, C. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000120241.50061.e4 · Cited by 305
Update on time-of-flight PET imaging
Surti, S. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.145029 · Cited by 303
Pak, K., Cheon, G. J., Nam, H.-Y., Kim, S.-J., Kang, K. W., Chung, J.-K., Kim, E. E., & Lee, D. S. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.133801 · Cited by 301
Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings
de Galiza Barbosa, F., Queiroz, M. A., Nunes, R. F., Costa, L. B., Zaniboni, E. C., Marin, J. F. G., Cerri, G. G., & Buchpiguel, C. A. (2020) · Cancer Imaging · doi:10.1186/s40644-020-00300-7 · Cited by 288
Impact of Time-of-Flight on PET Tumor Detection
Kadrmas, D. J., Casey, M. E., Conti, M., Jakoby, B. W., Lois, C., & Townsend, D. W. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.063016 · Cited by 277
Liu, I. J., Zafar, M. B., Lai, Y.-H., Segall, G. M., & Terris, M. K. (2001) · Urology · doi:10.1016/s0090-4295(00)00896-7 · Cited by 267
Teoh, E. J., McGowan, D. R., Macpherson, R. E., Bradley, K. M., & Gleeson, F. V. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.159301 · Cited by 265
Samarin, A., Burger, C., Wollenweber, S. D., Crook, D. W., Burger, I. A., Schmid, D. T., von Schulthess, G. K., & Kuhn, F. P. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2113-0 · Cited by 251 · cited 1×
“Systematic underestimation of SUV in bone tissue or lesions close to the bone of >10% compared to PET/CT has been described [60,62], whereas SUV differences were <5% in other normal tissues [60].”
BackgroundSchmidt-Hansen, M., Baldwin, D. R., Hasler, E., Zamora, J., Abraira, V., & Roqué i Figuls, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009519.pub2 · Cited by 248
Studies of a Next-Generation Silicon-Photomultiplier–Based Time-of-Flight PET/CT System
Hsu, D. F. C., Ilan, E., Peterson, W. T., Uribe, J., Lubberink, M., & Levin, C. S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.189514 · Cited by 241 · cited 1×
“Using a modern SiPM-equipped PET scanner with 20 cm axial FOV and PL reconstruction [54], Trägårdh et al.”
MethodRouzet, F., Chequer, R., Benali, K., Lepage, L., Ghodbane, W., Duval, X., Iung, B., Vahanian, A., Le Guludec, D., & Hyafil, F. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.141895 · Cited by 230
Deep Learning for PET Image Reconstruction
Reader, A. J., Corda, G., Mehranian, A., Costa-Luis, C. D., Ellis, S., & Schnabel, J. A. (2021) · IEEE Transactions on Radiation and Plasma Medical Sciences · doi:10.1109/trpms.2020.3014786 · Cited by 228
Schäfer, J. F., Gatidis, S., Schmidt, H., Gückel, B., Bezrukov, I., Pfannenberg, C. A., Reimold, M., Ebinger, M., Fuchs, J., Claussen, C. D., et al. (2014) · Radiology · doi:10.1148/radiol.14131732 · Cited by 215 · cited 3×
“However, several sources of error exist, including extracorporeal components such as headphones, dense hair or MR coils [59], incorrect attenuation correction factors for bone and lung tissue [60], incorrect segmentation of such compartments, and MR image truncation [61].”
BackgroundBayesian reconstruction of PET images: methodology and performance analysis
Mumcuoglu, E. Ü., Leahy, R. M., & Cherry, S. R. (1996) · Physics in Medicine and Biology · doi:10.1088/0031-9155/41/9/015 · Cited by 214
Repeatability of SUV in Oncologic 18F-FDG PET
Lodge, M. A. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.186353 · Cited by 214
Higashi, K., Ueda, Y., Sakurai, A., MingWang, X., Xu, L., Murakami, M., Seki, H., Oguchi, M., Taki, S., Nambu, Y., et al. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000367 · Cited by 210
Akamatsu, G., Ishikawa, K., Mitsumoto, K., Taniguchi, T., Ohya, N., Baba, S., Abe, K., & Sasaki, M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.103861 · Cited by 206
Dimitrakopoulou-Strauss, A., Pan, L., & Sachpekidis, C. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04843-6 · Cited by 203 · cited 1×
“Likewise, advances in kinetic modeling and parametric PET imaging [37] for the prediction and validation of pharmacokinetic models, e.”
MethodMolecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction
Thackeray, J. T., Derlin, T., Haghikia, A., Napp, L. C., Wang, Y., Ross, T. L., Schäfer, A., Tillmanns, J., Wester, H. J., Wollert, K. C., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.09.008 · Cited by 199
Improvement in Lesion Detection with Whole-Body Oncologic Time-of-Flight PET
El Fakhri, G., Surti, S., Trott, C. M., Scheuermann, J., & Karp, J. S. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.080382 · Cited by 198
(1993) · PubMed · Cited by 197
(2003) · PubMed · Cited by 190
Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response
Vanderhoek, M., Perlman, S. B., & Jeraj, R. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.093443 · Cited by 188
Dunet, V., Pomoni, A., Hottinger, A., Nicod-Lalonde, M., & Prior, J. O. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov148 · Cited by 183
Mehranian, A., & Reader, A. J. (2020) · IEEE Transactions on Radiation and Plasma Medical Sciences · doi:10.1109/trpms.2020.3004408 · Cited by 180
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems
Kaalep, A., Sera, T., Oyen, W., Krause, B. J., Chiti, A., Liu, Y., & Boellaard, R. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3853-7 · Cited by 174
Self-citationRowe, S. P., Pienta, K. J., Pomper, M. G., & Gorin, M. A. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.195255 · Cited by 170
Performance Evaluation of the Vereos PET/CT System According to the NEMA NU2-2012 Standard
Rausch, I., Ruiz, A., Valverde-Pascual, I., Cal-González, J., Beyer, T., & Carrio, I. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.215541 · Cited by 168 · cited 1×
“Additionally, the development of small SiPM elements has enabled small voxel sizes down to 1 × 1 × 1 mm3 [52] with potential superiority over PMT-based systems in reconstructed spatial resolution and quantitative accuracy in the case of small lesions [53–56].”
BackgroundVesselle, H., Salskov, A., Turcotte, E., Wiens, L., Schmidt, R., Jordan, C. D., Vallières, E., & Wood, D. E. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818307a7 · Cited by 165
Feasibility of state of the art PET/CT systems performance harmonisation
Kaalep, A., Sera, T., Rijnsdorp, S., Yaqub, M., Talsma, A., Lodge, M. A., & Boellaard, R. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3977-4 · Cited by 160 · cited 3×
“This has undermined any attempts to establish widely adoptable SUV thresholds unless rigorous harmonization measures are followed [101,103,181].”
BackgroundSelf-citationSeifert, R., Kessel, K., Schlack, K., Weber, M., Herrmann, K., Spanke, M., Fendler, W. P., Hadaschik, B., Kleesiek, J., Schäfers, M., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05040-1 · Cited by 160
Vallabhajosula, S., Killeen, R. P., & Osborne, J. R. (2010) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2010.02.004 · Cited by 158 · cited 1×
“These include physiological and pharmacological factors [31], the in vivo degradation of peptide-based PET radiopharmaceuticals [32], and interactions between the lesion microenvironment and radiopharmaceuticals [33–36].”
BackgroundRepeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
de Langen, A. J., Vincent, A., Velasquez, L. M., van Tinteren, H., Boellaard, R., Shankar, L. K., Boers, M., Smit, E. F., Stroobants, S., Weber, W. A., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.095299 · Cited by 157
Self-citationHasenclever, D., Kurch, L., Mauz-Körholz, C., Elsner, A., Georgi, T., Wallace, H., Landman-Parker, J., Moryl-Bujakowska, A., Cepelová, M., Karlén, J., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2715-9 · Cited by 157
(2005) · PubMed · Cited by 156
Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
Evans, B. J., King, A. T., Katsifis, A., Matesic, L., & Jamie, J. F. (2020) · Molecules · doi:10.3390/molecules25102314 · Cited by 154 · cited 1×
“These include physiological and pharmacological factors [31], the in vivo degradation of peptide-based PET radiopharmaceuticals [32], and interactions between the lesion microenvironment and radiopharmaceuticals [33–36].”
BackgroundAhn, S., Ross, S. G., Asma, E., Miao, J., Jin, X., Cheng, L., Wollenweber, S. D., & Manjeshwar, R. M. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/15/5733 · Cited by 153
PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients
Berthelsen, A. K., Holm, S., Loft, A., Klausen, T. L., Andersen, F., & Højgaard, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1784-1 · Cited by 151
Ilyas, H., Mikhaeel, N. G., Dunn, J. T., Rahman, F., Møller, H., Smith, D., & Barrington, S. F. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3953-z · Cited by 150
Performance of the new generation of whole-body PET/CT scanners: Discovery STE and Discovery VCT
Teräs, M., Tolvanen, T., Johansson, J. J., Williams, J. J., & Knuuti, J. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0493-3 · Cited by 146
Image-based point spread function implementation in a fully 3D OSEM reconstruction algorithm for PET
Rapisarda, E., Bettinardi, V, Thielemans, K., & Gilardi, M. C. (2010) · Physics in Medicine and Biology · doi:10.1088/0031-9155/55/14/012 · Cited by 142 · cited 16×
“Wickham et al. [147] investigated the relationship between subjective and quantified measures of image quality in 111 clinical [18F]FDG-PET/CT scans (oncology, hematology, and infection) using a PMT-based PET scanner with a 22.1 cm axial FOV [148].”
BackgroundInfluential(2004) · PubMed · Cited by 141
Fendler, W. P., Calais, J., Allen-Auerbach, M., Bluemel, C., Eberhardt, N., Emmett, L., Gupta, P., Hartenbach, M., Hope, T. A., Okamoto, S., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.190827 · Cited by 141
Rausch, I., Cal-González, J., Dapra, D., Gallowitsch, H. J., Lind, P., Beyer, T., & Minear, G. (2015) · EJNMMI Physics · doi:10.1186/s40658-015-0132-1 · Cited by 133 · cited 1×
“In contrast, a SiPM system with 100% detector coverage and 214 ps timing resolution [47] can offer increased system sensitivity over a comparable PMT system with lutetium oxyorthosilicate (LSO) crystals [48] that exceeds the expected difference based on the slightly larger axial FOV (16.”
Backgroundvan den Hoff, J., Oehme, L., Schramm, G., Maus, J., Lougovski, A., Petr, J., Beuthien-Baumann, B., & Hofheinz, F. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-77 · Cited by 127 · cited 1×
“Lesional uptake of [18F]FDG is more or less irreversible in neoplastic cells [68,69] due to intracellular trapping of the phosphorylated molecule, although reversible uptake has been demonstrated in inflammatory tissue [18].”
BackgroundSelf-citationPrognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer
Chung, H. H., Kim, J. W., Han, K. H., Eo, J. S., Kang, K. W., Park, N.-H., Song, Y.-S., Chung, J.-K., & Kang, S.-B. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.11.002 · Cited by 126
Lasnon, C., Desmonts, C., Quak, E., Gervais, R., Do, P., Dubos-Arvis, C., & Aide, N. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2391-1 · Cited by 125
Performance evaluation of the next generation solid-state digital photon counting PET/CT system
Zhang, J., Maniawski, P., & Knopp, M. V. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0448-7 · Cited by 123
Zhang, Y.-Q., Hu, P.-C., Wu, R.-Z., Gu, Y.-S., Chen, S.-G., Yu, H.-J., Wang, X.-Q., Song, J., & Shi, H.-C. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04823-w · Cited by 123
Pan, T., Einstein, S. A., Kappadath, S. C., Grogg, K. S., Lois Gomez, C., Alessio, A. M., Hunter, W. C., El Fakhri, G., Kinahan, P. E., & Mawlawi, O. R. (2019) · Medical Physics · doi:10.1002/mp.13576 · Cited by 122 · cited 2×
“If, for example, a SiPM system with low relative coverage of <60% and a modest timing resolution of 382 ps [44,45] is compared to a bismuth germanate (BGO) PMT scanner with similar axial FOV length [46], the SiPM system’s sensitivity can be similar or even slightly inferior (20.”
BackgroundResultIncreased Glucose Uptake in Visceral Versus Subcutaneous Adipose Tissue Revealed by PET Imaging
Christen, T., Sheikine, Y., Rocha, V. Z., Hurwitz, S., Goldfine, A. B., Di Carli, M., & Libby, P. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.06.004 · Cited by 120 · cited 1×
“This correlation can be partly explained mathematically by the incorrect estimation of the distribution volume in obese patients if total body mass is used instead of lean body mass (due to the relatively low [18F]FDG accumulation in fat tissue [4]) [5].”
BackgroundRelation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
Khalaf, M., Abdel-Nabi, H., Baker, J., Shao, Y., Lamonica, D., & Gona, J. (2008) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-1-13 · Cited by 116
Fanti, S., Minozzi, S., Morigi, J. J., Giesel, F., Ceci, F., Uprimny, C., Hofman, M. S., Eiber, M., Schwarzenbock, S., Castellucci, P., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3725-1 · Cited by 113
Management of respiratory motion in PET/computed tomography: the state of the art
Pépin, A., Daouk, J., Bailly, P., Hapdey, S., & Meyer, M.-E. (2014) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000048 · Cited by 112 · cited 1×
“Several techniques for respiratory motion correction have been proposed [89].”
MethodBüsing, K. A., Schönberg, S. O., Brade, J., & Wasser, K. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.10.014 · Cited by 111 · cited 5×
“Mildly to moderately reduced kidney function (estimated glomerular filtration rate <60 ml/min) may not influence either normal organ SUV or blood pool clearance [6,7], unless kidney function is so far reduced that the patient requires hemodialysis [8].”
BackgroundInfluentialSher, A., Lacoeuille, F., Fosse, P., Vervueren, L., Cahouet-Vannier, A., Dabli, D., Bouchet, F., & Couturier, O. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0177-8 · Cited by 111
Effects of Nonionic Intravenous Contrast Agents at PET/CT Imaging: Phantom and Canine Studies
Nakamoto, Y., Chin, B. B., Kraitchman, D. L., Lawler, L. P., Marshall, L. T., & Wahl, R. L. (2003) · Radiology · doi:10.1148/radiol.2273020299 · Cited by 111
Eskian, M., Alavi, A., Khorasanizadeh, M., Viglianti, B. L., Jacobsson, H., Barwick, T. D., Meysamie, A., Yi, S. K., Iwano, S., Bybel, B., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4194-x · Cited by 109 · cited 3×
“Conversely, raising blood glucose and/or insulin levels increases [18F]FDG uptake in the liver, skeletal muscles, and myocardium mainly via GLUT2 and 4 [1,6,22].”
BackgroundTeoh, E. J., McGowan, D. R., Bradley, K. M., Belcher, E., Black, E., & Gleeson, F. V. (2016) · European Radiology · doi:10.1007/s00330-015-3832-y · Cited by 109
Quak, E., Le Roux, P.-Y., Hofman, M. S., Robin, P., Bourhis, D., Callahan, J., Binns, D., Desmonts, C., Salaun, P.-Y., Hicks, R. J., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3128-0 · Cited by 107 · cited 2×
“To correct for these increases, an additional Gaussian filter can be applied during image reconstruction or to the final images [100,102].”
BackgroundPET quantification: strategies for partial volume correction
Bettinardi, V., Castiglioni, I., De Bernardi, E., & Gilardi, M. C. (2014) · Clinical and Translational Imaging · doi:10.1007/s40336-014-0066-y · Cited by 105 · cited 2×
“The larger the voxel size, the higher the likelihood of underestimating both the true maximum activity within the lesion and the variety and heterogeneity of activities [42].”
BackgroundSurti, S., Scheuermann, J., El Fakhri, G., Daube-Witherspoon, M. E., Lim, R., Abi-Hatem, N., Moussallem, E., Benard, F., Mankoff, D., & Karp, J. S. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086678 · Cited by 104
Masuda, Y., Kondo, C., Matsuo, Y., Uetani, M., & Kusakabe, K. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060590 · Cited by 104 · cited 1×
“These studies have demonstrated that image quality (namely image noise) in overweight patients >80–90 kg benefits especially from increased acquisition time per bed position [77,151,152].”
Background(2005) · PubMed · Cited by 103
Characterization of 18 F-Fluorodeoxyglucose Uptake Pattern in Noninfected Prosthetic Heart Valves
Mathieu, C., Mikaïl, N., Benali, K., Iung, B., Duval, X., Nataf, P., Jondeau, G., Hyafil, F., Le Guludec, D., & Rouzet, F. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005585 · Cited by 102
The clinical efficacy of 18F-FDG-PET/CT in benign and malignant musculoskeletal tumors
Shin, D.-S., Shon, O., Han, D.-S., et al. (2008) · Annals of Nuclear Medicine · doi:10.1007/s12149-008-0151-2 · Cited by 102
Qualitative and Quantitative Comparison of PET/CT and PET/MR Imaging in Clinical Practice
Al-Nabhani, K. Z., Syed, R., Michopoulou, S., Alkalbani, J., Afaq, A., Panagiotidis, E., O’Meara, C., Groves, A., Ell, P., & Bomanji, J. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123547 · Cited by 101 · cited 1×
“However, systematically different normal organ SUVs have been reported for [18F]FDG as well, which most likely result from MR-AC inaccuracies [60,65,66].”
BackgroundYoshizawa, H., Gazes, Y., Stern, Y., Miyata, Y., & Uchiyama, S. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2013.10.009 · Cited by 100 · cited 1×
“Normal brain [18F]FDG uptake varies with age, sex, and the presence or absence of diabetes mellitus [1,6,9,10].”
BackgroundWerner, M. K., Parker, J. A., Kolodny, G. M., English, J. R., & Palmer, M. R. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.09.2516 · Cited by 100
Lindström, E., Sundin, A., Trampal, C., Lindsjö, L., Ilan, E., Danfors, T., Antoni, G., Sörensen, J., & Lubberink, M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.200790 · Cited by 99
Nestle, U., Schaefer-Schuler, A., Kremp, S., Gröschel, A., Hellwig, D., Rübe, C., & Kirsch, C. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0252-x · Cited by 98
Akamatsu, G., Mitsumoto, K., Taniguchi, T., Tsutsui, Y., Baba, S., & Sasaki, M. (2014) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.09.030 · Cited by 96 · cited 1×
“This improves reconstructed spatial resolution [97,98] and increases lesion SUV [99,100] but can lead to overestimation of the true activity due to so-called Gibbs’ artifacts [92,93].”
BackgroundUpdate on latest advances in time-of-flight PET
Surti, S., & Karp, J. S. (2020) · Physica Medica · doi:10.1016/j.ejmp.2020.10.031 · Cited by 96 · cited 4×
“The effect of image reconstruction algorithms on quantitative accuracy in PET has been studied extensively, and three recent reviews cover current knowledge and views on time of flight (TOF) integration [44] as well as PSF modelling and Bayesian penalized likelihood (PL) reconstruction [92,93].”
BackgroundResultInfluentialHeusch, P., Buchbender, C., Beiderwellen, K., Nensa, F., Hartung-Knemeyer, V., Lauenstein, T. C., Bockisch, A., Forsting, M., Antoch, G., & Heusner, T. A. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.01.008 · Cited by 96 · cited 1×
“However, systematically different normal organ SUVs have been reported for [18F]FDG as well, which most likely result from MR-AC inaccuracies [60,65,66].”
BackgroundComparison of image quality and lesion detection between digital and analog PET/CT
López-Mora, D. A., Flotats, A., Fuentes-Ocampo, F., Camacho, V., Fernández, A., Ruiz, A., Duch, J., Sizova, M., Domènech, A., Estorch, M., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-4260-z · Cited by 94
Lee, P., Bazan, J. G., Lavori, P. W., Weerasuriya, D. K., Quon, A., Le, Q.-T., Wakelee, H. A., Graves, E. E., & Loo, B. W. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.05.001 · Cited by 92
Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
Mettler, J., Müller, H., Voltin, C.-A., Baues, C., Klaeser, B., Moccia, A., Borchmann, P., Engert, A., Kuhnert, G., Drzezga, A., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.210047 · Cited by 89
Self-citationSchaefferkoetter, J., Casey, M., Townsend, D., & El Fakhri, G. (2013) · Physics in Medicine and Biology · doi:10.1088/0031-9155/58/5/1465 · Cited by 85
Jensen, T. E., Sylow, L., Rose, A. J., Madsen, A. B., Angin, Y., Maarbjerg, S. J., & Richter, E. A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.07.005 · Cited by 83 · cited 1×
“Physical exercise increases skeletal muscle [18F]FDG uptake via GLUT4 [23].”
BackgroundReduction of 18 F-FDG Dose in Clinical PET/MR Imaging by Using Silicon Photomultiplier Detectors
Sekine, T., Delso, G., Zeimpekis, K. G., de Galiza Barbosa, F., ter Voert, E. E. G. W., Huellner, M., & Veit-Haibach, P. (2018) · Radiology · doi:10.1148/radiol.2017162305 · Cited by 79
Quantitative implications of the updated EARL 2019 PET–CT performance standards
Kaalep, A., Burggraaff, C. N., Pieplenbosch, S., Verwer, E. E., Sera, T., Zijlstra, J., Hoekstra, O. S., Oprea-Lager, D. E., & Boellaard, R. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0257-8 · Cited by 79
Self-citationPerformance Characteristics of the Whole-Body Discovery IQ PET/CT System
Reynés-Llompart, G., Gámez-Cenzano, C., Romero-Zayas, I., Rodríguez-Bel, L., Vercher-Conejero, J. L., & Martí-Climent, J. M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.185561 · Cited by 78 · cited 2×
“If, for example, a SiPM system with low relative coverage of <60% and a modest timing resolution of 382 ps [44,45] is compared to a bismuth germanate (BGO) PMT scanner with similar axial FOV length [46], the SiPM system’s sensitivity can be similar or even slightly inferior (20.”
BackgroundResultVariance of SUVs for FDG-PET/CT is Greater in Clinical Practice Than Under Ideal Study Settings
Kumar, V., Nath, K., Berman, C. G., Kim, J., Tanvetyanon, T., Chiappori, A. A., Gatenby, R. A., Gillies, R. J., & Eikman, E. A. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318279ffdf · Cited by 76
(1995) · PubMed · Cited by 76
Initial experience with a SiPM-based PET/CT scanner: influence of acquisition time on image quality
Sonni, I., Baratto, L., Park, S., Hatami, N., Srinivas, S., Davidzon, G., Gambhir, S. S., & Iagaru, A. (2018) · EJNMMI Physics · doi:10.1186/s40658-018-0207-x · Cited by 74 · cited 1×
“However, systematic SUVmax increases of >5–10% have not typically been observed at acquisition times per bed position of >30–60s, at least during investigations of SiPM-equipped systems and/or patients with BMI <25 kg/m2 [79,81,82].”
BackgroundNaswa, N., Sharma, P., Gupta, S. K., Karunanithi, S., Reddy, R. M., Patnecha, M., Lata, S., Kumar, R., Malhotra, A., & Bal, C. S. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31827a216b · Cited by 74
Confounders in FDG-PET/CT Imaging of Suspected Prosthetic Valve Endocarditis
Scholtens, A. M., Swart, L. E., Verberne, H. J., Tanis, W., Lam, M. G. E. H., & Budde, R. P. J. (2016) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2016.01.024 · Cited by 74
Messerli, M., Stolzmann, P., Egger-Sigg, M., Trinckauf, J., D’Aguanno, S., Burger, I. A., von Schulthess, G. K., Kaufmann, P. A., & Huellner, M. W. (2018) · EJNMMI Physics · doi:10.1186/s40658-018-0223-x · Cited by 73
New PET technologies – embracing progress and pushing the limits
Aide, N., Lasnon, C., Kesner, A., Levin, C. S., Buvat, I., Iagaru, A., Hermann, K., Badawi, R. D., Cherry, S. R., Bradley, K. M., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05390-4 · Cited by 73 · cited 2×
“The effect of image reconstruction algorithms on quantitative accuracy in PET has been studied extensively, and three recent reviews cover current knowledge and views on time of flight (TOF) integration [44] as well as PSF modelling and Bayesian penalized likelihood (PL) reconstruction [92,93].”
Background(2007) · PubMed · Cited by 71
Howard, B. A., Morgan, R., Thorpe, M. P., Turkington, T. G., Oldan, J., James, O. G., & Borges-Neto, S. (2017) · Annals of Nuclear Medicine · doi:10.1007/s12149-017-1192-1 · Cited by 70
Alberts, I., Sachpekidis, C., Prenosil, G., Viscione, M., Bohn, K. P., Mingels, C., Shi, K., Ashar-Oromieh, A., & Rominger, A. (2021) · Annals of Nuclear Medicine · doi:10.1007/s12149-021-01588-6 · Cited by 70 · cited 2×
“However, standardized reading criteria do not negate the dissimilarities in the images obtained using different types of PET hardware and methods of image reconstruction, and both SiPM technology [79] and PSF reconstruction [225] have been found to result in systematically higher lesion conspicuity despite standardize…”
BackgroundModeling and Predicting Tumor Response in Radioligand Therapy
Kletting, P., Thieme, A., Eberhardt, N., Rinscheid, A., D’Alessandria, C., Allmann, J., Wester, H.-J., Tauber, R., Beer, A. J., Glatting, G., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.210377 · Cited by 67 · cited 1×
“, in radioligand therapy [38] or in neurology [39,40], have been discussed elsewhere.”
BackgroundBeyer, T., Lassen, M. L., Boellaard, R., Delso, G., Yaqub, M., Sattler, B., & Quick, H. H. (2016) · Magnetic Resonance Materials in Physics, Biology and Medicine · doi:10.1007/s10334-015-0505-4 · Cited by 66 · cited 2×
“However, several sources of error exist, including extracorporeal components such as headphones, dense hair or MR coils [59], incorrect attenuation correction factors for bone and lung tissue [60], incorrect segmentation of such compartments, and MR image truncation [61].”
BackgroundSelf-citationIncreasing Uptake Time in FDG-PET: Standardized Uptake Values in Normal Tissues at 1 versus 3 h
Chin, B. B., Green, E. D., Turkington, T. G., Hawk, T. C., & Coleman, R. E. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0177-9 · Cited by 65 · cited 1×
“Normal organ SUV may either decline over time (blood pool, bowel, and fat tissue), remain relatively stable (liver and lung) or increase (cerebellum, spleen, bone marrow, and muscles) [72,73].”
BackgroundFuentes-Ocampo, F., López-Mora, D. A., Flotats, A., Paillahueque, G., Camacho, V., Duch, J., Fernández, A., Domènech, A., Estorch, M., & Carrió, I. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4256-0 · Cited by 65
Kramer, G. M., Frings, V., Hoetjes, N., Hoekstra, O. S., Smit, E. F., de Langen, A. J., & Boellaard, R. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170225 · Cited by 65 · cited 1×
“The SUV of tumor lesions, therefore, increases steadily over time after [18F]FDG injection [70,71].”
BackgroundSelf-citationCottereau, A.-S., Hapdey, S., Chartier, L., Modzelewski, R., Casasnovas, O., Itti, E., Tilly, H., Vera, P., Meignan, M. A., & Becker, S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180406 · Cited by 64
Rogasch, J. M., Suleiman, S., Hofheinz, F., Bluemel, S., Lukas, M., Amthauer, H., & Furth, C. (2020) · EJNMMI Physics · doi:10.1186/s40658-020-0270-y · Cited by 63 · cited 5×
“Clear), several phantom studies have shown that PL reconstruction can increase the CR of standardized sphere inserts compared to conventional TOF and PSF reconstruction [41,46,101,107,108].”
BackgroundInfluentialSelf-citationSchwyzer, M., Martini, K., Benz, D. C., Burger, I. A., Ferraro, D. A., Kudura, K., Treyer, V., von Schulthess, G. K., Kaufmann, P. A., Huellner, M. W., et al. (2020) · European Radiology · doi:10.1007/s00330-019-06498-w · Cited by 63
Boellaard, R., Rausch, I., Beyer, T., Delso, G., Yaqub, M., Quick, H. H., & Sattler, B. (2015) · Medical Physics · doi:10.1118/1.4930962 · Cited by 62 · cited 2×
“In such phantoms, inter-vendor differences in MR-AC maps [61] can lead to SUV differences in phantom spheres of 10–20% [58].”
BackgroundSelf-citationClinical evaluation of PET image reconstruction using a spatial resolution model
Andersen, F. L., Klausen, T. L., Loft, A., Beyer, T., & Holm, S. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2012.11.015 · Cited by 62
Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT
Zheng, S., Lin, R., Chen, S., Zheng, J., Lin, Z., Zhang, Y., Xue, Q., Chen, Y., Zhang, J., Lin, K., et al. (2021) · Annals of Nuclear Medicine · doi:10.1007/s12149-021-01673-w · Cited by 62
Sprinz, C., Zanon, M., Altmayer, S., Watte, G., Irion, K., Marchiori, E., & Hochhegger, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-20529-4 · Cited by 59 · cited 1×
“This suggests effects on SUV in obese patients that are specific for [18F]FDG, possibly stemming from the positive correlation between BMI and blood glucose [3,6].”
BackgroundWhat parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?
Kunikowska, J., Matyskiel, R., Toutounchi, S., Grabowska-Derlatka, L., Koperski, Ł., & Królicki, L. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2844-1 · Cited by 58
Iravani, A., & Hicks, R. J. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.234278 · Cited by 57
Grootjans, W., de Geus-Oei, L.-F., Meeuwis, A. P. W., van der Vos, C. S., Gotthardt, M., Oyen, W. J. G., & Visser, E. P. (2014) · European Radiology · doi:10.1007/s00330-014-3362-z · Cited by 57
Kluge, R., Chavdarova, L., Hoffmann, M., Kobe, C., Malkowski, B., Montravers, F., Kurch, L., Georgi, T., Dietlein, M., Wallace, W. H., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149072 · Cited by 56
Self-citationAalbersberg, E. A., der Veen, B. J. D. W., Versleijen, M. W. J., Saveur, L. J., Valk, G. D., Tesselaar, M. E. T., & Stokkel, M. P. M. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4117-x · Cited by 56 · cited 1×
“The influence of somatostatin analogues on the uptake of neuroendocrine tumors in somatostatin receptor-specific PET [28] and of antihormonal treatment on PSMA uptake in prostate cancer cells [29,30] are currently under investigation.”
BackgroundFendler, W. P., Calais, J., Eiber, M., Simko, J. P., Kurhanewicz, J., Santos, R. D., Feng, F. Y., Reiter, R. E., Rettig, M. B., Nickols, N. G., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04945-1 · Cited by 56
Radioligand studies: imaging and quantitative analysis
Lammertsma, A. A. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00100-1 · Cited by 55 · cited 1×
“, in radioligand therapy [38] or in neurology [39,40], have been discussed elsewhere.”
BackgroundReynés‐Llompart, G., Gámez‐Cenzano, C., Vercher‐Conejero, J. L., Sabaté‐Llobera, A., Calvo‐Malvar, N., & Martí‐Climent, J. M. (2018) · Medical Physics · doi:10.1002/mp.12986 · Cited by 55
Correction of scan time dependence of standard uptake values in oncological PET
van den Hoff, J., Lougovski, A., Schramm, G., Maus, J., Oehme, L., Petr, J., Beuthien-Baumann, B., Kotzerke, J., & Hofheinz, F. (2014) · EJNMMI Research · doi:10.1186/2191-219x-4-18 · Cited by 55 · cited 1×
“The SUV of tumor lesions, therefore, increases steadily over time after [18F]FDG injection [70,71].”
BackgroundSelf-citationA method for model-free partial volume correction in oncological PET
Hofheinz, F., Langner, J., Petr, J., Beuthien-Baumann, B., Oehme, L., Steinbach, J., Kotzerke, J., & van den Hoff, J. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-16 · Cited by 55 · cited 1×
“The recovery for lesions of a different shape and inhomogeneous tracer accumulation can differ widely from the figures presented [43], and it is therefore not possible to achieve reliable partial volume correction using these results.”
MethodSelf-citationWerner, R. A., Bundschuh, R. A., Bundschuh, L., Javadi, M. S., Leal, J. P., Higuchi, T., Pienta, K. J., Buck, A. K., Pomper, M. G., Gorin, M. A., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.217588 · Cited by 55
Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain
Wimberley, C., Lavisse, S., Hillmer, A. T., Hinz, R., Turkheimer, F., & Zanotti‐Fregonara, P. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05248-9 · Cited by 54 · cited 1×
“, in radioligand therapy [38] or in neurology [39,40], have been discussed elsewhere.”
BackgroundImprovement in PET/CT image quality in overweight patients with PSF and TOF
Taniguchi, T., Akamatsu, G., Kasahara, Y., Mitsumoto, K., Baba, S., Tsutsui, Y., Himuro, K., Mikasa, S., Kidera, D., & Sasaki, M. (2015) · Annals of Nuclear Medicine · doi:10.1007/s12149-014-0912-z · Cited by 53
Rogasch, J. M., Hofheinz, F., Lougovski, A., Furth, C., Ruf, J., Großer, O. S., Mohnike, K., Hass, P., Walke, M., Amthauer, H., et al. (2014) · EJNMMI Physics · doi:10.1186/2197-7364-1-12 · Cited by 53 · cited 1×
“This improves reconstructed spatial resolution [97,98] and increases lesion SUV [99,100] but can lead to overestimation of the true activity due to so-called Gibbs’ artifacts [92,93].”
BackgroundSelf-citationToriihara, A., Nobashi, T., Baratto, L., Duan, H., Moradi, F., Park, S., Hatami, N., Aparici, C. M., Davidzon, G., & Iagaru, A. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.232504 · Cited by 53
Han, S., Kim, H., Kim, Y. J., Suh, C. H., & Woo, S. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.18.19734 · Cited by 52
Park, S. G., Lee, J. H., Lee, W. A., & Han, K. M. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.07.003 · Cited by 51
Caribé, P. R. R. V., Koole, M., D’Asseler, Y., Van Den Broeck, B., & Vandenberghe, S. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0264-9 · Cited by 51
Systematic Evaluation of Phantom Fluids for Simultaneous PET/MR Hybrid Imaging
Ziegler, S., Braun, H., Ritt, P., Hocke, C., Kuwert, T., & Quick, H. H. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.116376 · Cited by 50 · cited 1×
“It should also be noted that cross-calibration of PET/MRI scanners is generally hampered by waterfilled phantoms, which are commonly used for SUV calibration in PET/CT and can produce substantial artifacts in the MR-AC sequence with corresponding SUV errors [63,64].”
BackgroundTrägårdh, E., Minarik, D., Almquist, H., Bitzén, U., Garpered, S., Hvittfelt, E., Olsson, B., & Oddstig, J. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0535-4 · Cited by 50 · cited 3×
“In contrast, SUVmax can vary substantially because this is, by definition, the outlier, which is most affected by increasing relative errors with declining count statistics [76,80].”
BackgroundInfluentialEnhancing Cardiac PET by Motion Correction Techniques
Rubeaux, M., Doris, M. K., Alessio, A., & Slomka, P. J. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0825-2 · Cited by 48 · cited 1×
“In cardiac PET imaging, contraction of the myocardium further contributes to the quantitative inaccuracy of uncorrected static PET protocols [90,91].”
BackgroundVanderhoek, M., Perlman, S. B., & Jeraj, R. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.113332 · Cited by 47
te Riet, J., Rijnsdorp, S., Roef, M. J., & Arends, A. J. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0262-y · Cited by 46
Salvadori, J., Imbert, L., Perrin, M., Karcher, G., Lamiral, Z., Marie, P.-Y., & Verger, A. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0526-5 · Cited by 44
Wen, W., Xuan, D., Hu, Y., Li, X., Liu, L., & Xu, D. (2019) · PLOS ONE · doi:10.1371/journal.pone.0225959 · Cited by 44
Rogasch, J. M., Steffen, I. G., Hofheinz, F., Großer, O. S., Furth, C., Mohnike, K., Hass, P., Walke, M., Apostolova, I., & Amthauer, H. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0111-5 · Cited by 43 · cited 2×
“This effect is especially prominent in low-contrast lesions [95].”
BackgroundSelf-citationFurth, C., Amthauer, H., Hautzel, H., Steffen, I. G., Ruf, J., Schiefer, J., Schönberger, S., Henze, G., Grandt, R., Hundsdoerfer, P., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq557 · Cited by 43
Self-citationObserver Variation in Interpreting 18F-FDG PET/CT Findings for Lymphoma Staging
Hofman, M. S., Smeeton, N. C., Rankin, S. C., Nunan, T., & O'Doherty, M. J. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.064121 · Cited by 41
Takemiya, K., Ning, X., Seo, W., Wang, X., Mohammad, R., Joseph, G., Titterington, J. S., Kraft, C. S., Nye, J. A., Murthy, N., et al. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2018.02.011 · Cited by 40
Gating Approaches in Cardiac PET Imaging
Lassen, M. L., Kwiecinski, J., & Slomka, P. J. (2019) · PET Clinics · doi:10.1016/j.cpet.2018.12.008 · Cited by 38 · cited 1×
“In cardiac PET imaging, contraction of the myocardium further contributes to the quantitative inaccuracy of uncorrected static PET protocols [90,91].”
BackgroundHoudu, B., Lasnon, C., Licaj, I., Thomas, G., Do, P., Guizard, A.-V., Desmonts, C., & Aide, N. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4151-8 · Cited by 37
Reynés-Llompart, G., Sabaté-Llobera, A., Llinares-Tello, E., Martí-Climent, J. M., & Gámez-Cenzano, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-46937-8 · Cited by 35
Ilan, E., Sandström, M., Velikyan, I., Sundin, A., Eriksson, B., & Lubberink, M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180380 · Cited by 34 · cited 1×
“It should be noted that tumor uptakes of [68Ga]Ga-PSMA-11 [74] and the somatostatin receptor-specific agents [68Ga]Ga-DOTATOC and -DOTATATE [75] have recently also been described as irreversible.”
BackgroundRingheim, A., Campos Neto, G. D. C., Anazodo, U., Cui, L., da Cunha, M. L., Vitor, T., Martins, K. M., Miranda, A. C. C., de Barboza, M. F., Fuscaldi, L. L., et al. (2020) · EJNMMI Research · doi:10.1186/s13550-020-0594-6 · Cited by 34 · cited 1×
“It should be noted that tumor uptakes of [68Ga]Ga-PSMA-11 [74] and the somatostatin receptor-specific agents [68Ga]Ga-DOTATOC and -DOTATATE [75] have recently also been described as irreversible.”
BackgroundOtani, T., Hosono, M., Kanagaki, M., Onishi, Y., Matsubara, N., Kawabata, K., & Kimura, H. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.18.20478 · Cited by 33
Paul, R., Johansson, R., Kellokumpu-Lehtinen, P. L., Söderström, K. O., & Kangas, L. (1985) · Research In Experimental Medicine · doi:10.1007/bf01854893 · Cited by 32
Improvements in PET Image Quality in Time of Flight (TOF) Simultaneous PET/MRI
Minamimoto, R., Levin, C., Jamali, M., Holley, D., Barkhodari, A., Zaharchuk, G., & Iagaru, A. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0939-8 · Cited by 32
Reproducibility and uptake time dependency of volume-based parameters on FDG-PET for lung cancer
Kitao, T., Hirata, K., Shima, K., Hayashi, T., Sekizawa, M., Takei, T., Ichimura, W., Harada, M., Kondo, K., & Tamaki, N. (2016) · BMC Cancer · doi:10.1186/s12885-016-2624-3 · Cited by 32
Lindström, E., Velikyan, I., Regula, N., Alhuseinalkhudhur, A., Sundin, A., Sörensen, J., & Lubberink, M. (2019) · Theranostics · doi:10.7150/thno.31970 · Cited by 32
18F-FDG uptake and clearance in patients with compromised renal function
Akers, S. R., Werner, T. J., Rubello, D., Alavi, A., & Cheng, G. (2016) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000513 · Cited by 31 · cited 1×
“Mildly to moderately reduced kidney function (estimated glomerular filtration rate <60 ml/min) may not influence either normal organ SUV or blood pool clearance [6,7], unless kidney function is so far reduced that the patient requires hemodialysis [8].”
BackgroundLy, J., Minarik, D., Edenbrandt, L., Wollmer, P., & Trägårdh, E. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0536-3 · Cited by 31
Aschoff, P., Plathow, C., Beyer, T., Lichy, M. P., Erb, G., Öksüz, M. Ö., Claussen, C. D., & Pfannenberg, C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1919-5 · Cited by 29
Kurita, Y., Ichikawa, Y., Nakanishi, T., Tomita, Y., Hasegawa, D., Murashima, S., Hirano, T., & Sakuma, H. (2020) · Annals of Nuclear Medicine · doi:10.1007/s12149-020-01446-x · Cited by 29
Atterton-Evans, V., Turner, J. R., Vivanti, A., & Robertson, T. (2018) · Journal of Nuclear Cardiology · doi:10.1007/s12350-018-1379-4 · Cited by 28
Dosani, M., Yang, R., McLay, M., Wilson, D., Liu, M., Yong-Hing, C. J., Hamm, J., Lund, C. R., Olson, R., & Schellenberg, D. (2019) · Current Oncology · doi:10.3747/co.26.4167 · Cited by 28
Zschaeck, S., Li, Y., Lin, Q., Beck, M., Amthauer, H., Bauersachs, L., Hajiyianni, M., Rogasch, J., Ehrhardt, V. H., Kalinauskaite, G., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0236841 · Cited by 28
Self-citationTrägårdh, E., Minarik, D., Brolin, G., Bitzén, U., Olsson, B., & Oddstig, J. (2020) · EJNMMI Physics · doi:10.1186/s40658-020-00298-8 · Cited by 27
Ceriani, L., Barrington, S., Biggi, A., Malkowski, B., Metser, U., Versari, A., Martelli, M., Davies, A., Johnson, P. W., Zucca, E., et al. (2017) · Hematological Oncology · doi:10.1002/hon.2339 · Cited by 26
Demirci, E., Akyel, R., Caner, B., Alan-Selçuk, N., Güven-Meşe, Ş., Ocak, M., & Kabasakal, L. (2020) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001219 · Cited by 26
Patient-specific optimisation of administered activity and acquisition times for 18F-FDG PET imaging
Wickham, F., McMeekin, H., Burniston, M., McCool, D., Pencharz, D., Skillen, A., & Wagner, T. (2017) · EJNMMI Research · doi:10.1186/s13550-016-0250-3 · Cited by 25
FDG PET/CT of the non-malignant liver in an increasingly obese world population
Keramida, G., & Peters, A. M. (2020) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12651 · Cited by 25
Impact of Point-Spread Function Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging
Aklan, B., Oehmigen, M., Beiderwellen, K., Ruhlmann, M., Paulus, D. H., Jakoby, B. W., Ritt, P., & Quick, H. H. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.154757 · Cited by 25
Fledelius, J., Khalil, A., Hjorthaug, K., & Frøkiær, J. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0223-6 · Cited by 24
Targeting Cardiovascular Implant Infection: Multimodality and Molecular Imaging
Sohns, J. M., Bavendiek, U., Ross, T. L., & Bengel, F. M. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.117.005376 · Cited by 24
Derwael, C., Lavergne, O., Lovinfosse, P., Nechifor, V., Salvé, M., Waltregny, D., Hustinx, R., & Withofs, N. (2020) · EJNMMI Research · doi:10.1186/s13550-020-0596-4 · Cited by 23
The Impact of Acquisition Time on Image Quality in Whole-Body 18F-FDG PET/CT for Cancer Staging
Hausmann, D., Dinter, D. J., Sadick, M., Brade, J., Schoenberg, S. O., & Busing, K. (2012) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.112.103291 · Cited by 21
Bjöersdorff, M., Oddstig, J., Karindotter-Borgendahl, N., Almquist, H., Zackrisson, S., Minarik, D., & Trägårdh, E. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0242-2 · Cited by 20
Practical issues and limitations of brain attenuation correction on a simultaneous PET-MR scanner
Mackewn, J. E., Stirling, J., Jeljeli, S., Gould, S.-M., Johnstone, R. I., Merida, I., Pike, L. C., McGinnity, C. J., Beck, K., Howes, O., et al. (2020) · EJNMMI Physics · doi:10.1186/s40658-020-00295-x · Cited by 20 · cited 1×
“However, several sources of error exist, including extracorporeal components such as headphones, dense hair or MR coils [59], incorrect attenuation correction factors for bone and lung tissue [60], incorrect segmentation of such compartments, and MR image truncation [61].”
BackgroundMoving the goalposts while scoring―the dilemma posed by new PET technologies
Rogasch, J. M. M., Boellaard, R., Pike, L., Borchmann, P., Johnson, P., Wolf, J., Barrington, S. F., & Kobe, C. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05403-2 · Cited by 20 · cited 2×
“The effect of image reconstruction algorithms on quantitative accuracy in PET has been studied extensively, and three recent reviews cover current knowledge and views on time of flight (TOF) integration [44] as well as PSF modelling and Bayesian penalized likelihood (PL) reconstruction [92,93].”
BackgroundSelf-citationComparison of FDG-PET/CT images between chronic renal failure patients on hemodialysis and controls.
(2015) · Europe PMC (PubMed Central) · Cited by 19
Frood, R., Prestwich, R., Tsoumpas, C., Murray, P., Franks, K., & Scarsbrook, A. (2018) · Clinical Oncology · doi:10.1016/j.clon.2018.01.005 · Cited by 19
Chicheportiche, A., Goshen, E., Godefroy, J., Grozinsky‐Glasberg, S., Oleinikov, K., Meirovitz, A., Gross, D. J., & Ben‐Haim, S. (2021) · EJNMMI Physics · doi:10.1186/s40658-021-00359-6 · Cited by 19
Fin, L., Bailly, P., Daouk, J., & Meyer, M. (2009) · Medical Physics · doi:10.1118/1.3152116 · Cited by 18
Effective sensitivity in 3D PET: the impact of detector dead time on 3D system performance
Bailey, D. L., Meikle, S. R., & Jones, T. (1997) · IEEE Transactions on Nuclear Science · doi:10.1109/23.596984 · Cited by 17
Mathy, C. S., Mayr, T., Kürpig, S., Meisenheimer, M., Dolscheid‐Pommerich, R., Stoffel‐Wagner, B., Kristiansen, G., Essler, M., Muders, M. H., & Bundschuh, R. A. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03583-w · Cited by 17 · cited 1×
“The influence of somatostatin analogues on the uptake of neuroendocrine tumors in somatostatin receptor-specific PET [28] and of antihormonal treatment on PSMA uptake in prostate cancer cells [29,30] are currently under investigation.”
BackgroundErdogan, M., Erdemoglu, E., Evrimler, Ş., Hanedan, C., & Şengül, S. S. (2019) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001091 · Cited by 16
Positron Emission Tomography Imaging of Macrophages in Cancer
Parker, C. C., & Lapi, S. E. (2021) · Cancers · doi:10.3390/cancers13081921 · Cited by 16
Li, C.-Y., Klohr, S., Sadick, H., Weiss, C., Hoermann, K., Schoenberg, S. O., & Sadick, M. (2014) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.114.141192 · Cited by 15
Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens
Geismar, J. H., Stolzmann, P., Sah, B.-R., Burger, I. A., Seifert, B., Delso, G., von Schulthess, G. K., Veit-Haibach, P., & Husmann, L. (2015) · Acta Radiologica Open · doi:10.1177/2047981614560076 · Cited by 15
Respiratory-gated 18F-FDG PET/CT for the diagnosis of liver metastasis
Suenaga, Y., Kitajima, K., Aoki, H., Okunaga, T., Kono, A., Matsumoto, I., Fukumoto, T., Tanaka, K., & Sugimura, K. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.05.019 · Cited by 15
Impacts of time interval on 18F-FDG uptake for PET/CT in normal organs: A systematic review
Wang, R., Chen, H., & Fan, C. (2018) · Medicine · doi:10.1097/md.0000000000013122 · Cited by 15 · cited 1×
“Normal organ SUV may either decline over time (blood pool, bowel, and fat tissue), remain relatively stable (liver and lung) or increase (cerebellum, spleen, bone marrow, and muscles) [72,73].”
Background
Research works printed but not linked: 1
- Guo, 2020, Quantification Accuracy Using Bayesian Penalized Likelihood Based Reconstruction on 68Ga PET-CT, J. Nucl. Med., 61, 162
Cited by
Li, X., Zhang, L., Yang, J., & Teng, F. (2024) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-024-00863-x · Cited by 133
“AI techniques have been employed to analyze nuclear medicine images, including PET and single-photon emission computed tomography (SPECT), enabling automated lesion detection, quantification, and prediction of patient outcomes [37, 38].”
Heydarheydari, S., Birgani, M. J. T., & Rezaeijo, S. M. (2023) · Polish Journal of Radiology · doi:10.5114/pjr.2023.130815 · Cited by 50
“However, the interpretation of PET images is often subjective and dependent on the operator, which can lead to errors and inconsistencies in the segmentation of tumors [6,7].”
Background[18F]FDG PET/CT: EANM procedure guidelines for tumour imaging: version 3.0
Boellaard, R., Herrmann, K., Barrington, S. F., Cranston, I., Mottaghy, F. M., Hoekstra, C. J., Beyer, T., Pike, L. C., Willemsen, A., Graham, M. M., et al. (2025) · The EANM Journal · doi:10.1016/j.eanmj.2025.100006 · Cited by 61
Self-citationvan Lith, S. A. M., Pruis, I. J., Tolboom, N., et al. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.265738 · Cited by 26
Self-citationThe value of artificial intelligence in PSMA PET: a pathway to improved efficiency and results
Dadgar, H., Hong, X., Karimzadeh, R., Ibragimov, B., Majidpour, J., Arabi, H., Al‐Ibraheem, A., Khalaf, A. N., Anwar, F., Marafi, F., et al. (2025) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.25.03640-4 · Cited by 15
Metadata
- Authors
- Rogasch, J. M. M., Hofheinz, F., van Heek, L., Voltin, C.-A., Boellaard, R., & Kobe, C.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- Helmholtz-Zentrum Dresden-Rossendorf (DE)
- University of Cologne (DE)
- Amsterdam University Medical Centers (NL)
- Corresponding author
- Kobe, Carsten
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2022-02-10
- Volume
- 12
- Issue
- 2
- Pages
- 451
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC8871060
- OpenAlex
- W4211063369
- Cited by
- 57
- References
- 239
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 4 · 2023: 10 · 2022: 5
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Deutsche Forschungsgemeinschaft
- Berlin Institute of Health
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- positron emission tomography, quantitative accuracy, image interpretation, PET quantification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.